Diagnostic strategy for occult hepatitis B virus infection

World Journal of Gastroenterology

Volumn 17, Issue 12, 2011, Pages 1553-1557

  Ocana, Sara ^a   Casas, Maria Luisa ^a   Buhigas, Ingrid ^a   Lledo, Jose Luis ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

Anti HBc; Hepatitis B surface antigen; Hepatitis B virus DNA; Occult hepatitis B virus infection

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ANTIBODY DETECTION; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GOLD STANDARD; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; NONHUMAN; OCCULT HEPATITIS B; SCREENING TEST; SEROLOGY; VIREMIA; VIRUS DETECTION; VIRUS HEPATITIS; VIRUS TRANSMISSION;

EID: 79955938981     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i12.1553     Document Type: Article

References (20)

1. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR, Zoulim F. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49: 652-657
2. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002; 2: 479-486
3. Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med 2010; 48: 23-29
4. Qin Y, Zhang J, Mao R, Guo H, Yin Y, Wu X, Weng X, Wands J, Tong S. Prevalence of basal core promoter and precore mutations in Chinese chronic hepatitis B patients and correlation with serum HBeAG titers. J Med Virol 2009; 81: 807-814
5. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001; 34: 1225-1241
6. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. Control of cccDNA function in hepatitis B virus infection. J Hepatol 2009; 51: 581-592
7. Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat 2010; 17: 1-15
8. Gerlich WH, Glebe D, Schüttler CG. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepat 2007; 14 Suppl 1: 16-21
9. Minegishi K, Yoshikawa A, Kishimoto S, Yugi H, Yokoya N, Sakurada M, Kiyokawa H, Nishioka K. Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening. Vox Sang 2003; 84: 287-291
10. Weber B. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 2006; 78 Suppl 1: S59-S65
11. Hollinger FB. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat 2007; 14 Suppl 1: 11-15
12. La'ulu SL, Roberts WL. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays. Am J Clin Pathol 2006; 125: 748-751
13. Michalak TI. Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model. Immunol Rev 2000; 174: 98-111
14. Mulrooney-Cousins PM, Michalak TI. Persistent occult hepatitis B virus infection: experimental findings and clinical implications. World J Gastroenterol 2007; 13: 5682-5686
15. Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001; 80: 63-71
16. González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion 2010; 50: 221-230
17. Allain JP, Candotti D. Diagnostic algorithm for HBV safe transfusion. Blood Transfus 2009; 7: 174-182
18. Georgiadou SP, Zachou K, Liaskos C, Gabeta S, Rigopoulou EI, Dalekos GN. Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver Int 2009; 29: 434-442
19. Ozaslan E. Which level of immunosuppression is harmful for occult hepatitis B virus infection? Liver Int 2009; 29: 1126-1127; author reply 1127-1128
20. Kwon CI, Hwang SG, Shin SJ, Chang SW, Kim SY, Ko KH, Hong SP, Park PW, Rim KS, Kang MS, Chung HJ, Hong SP. Occult hepatitis B virus infection in pregnant woman and its clinical implication. Liver Int 2008; 28: 667-674